{"id":"https://openalex.org/W2074636621","doi":"https://doi.org/10.1111/j.1600-0447.1984.tb06859.x","title":"Relationships Between Drug Concentrations in Serum and CSF, Clinical Effects and Monoaminergic Variables in Schizophrenic Patients Treated with Sulpiride or Chlorpromazine","display_name":"Relationships Between Drug Concentrations in Serum and CSF, Clinical Effects and Monoaminergic Variables in Schizophrenic Patients Treated with Sulpiride or Chlorpromazine","alternate_titles":[],"publication_year":1984,"publication_date":"1984-01-01","ids":{"openalex":"https://openalex.org/W2074636621","doi":"https://doi.org/10.1111/j.1600-0447.1984.tb06859.x","mag":"2074636621","pmid":"https://pubmed.ncbi.nlm.nih.gov/6199949"},"language":"en","primary_location":{"id":"doi:10.1111/j.1600-0447.1984.tb06859.x","doi":"https://doi.org/10.1111/j.1600-0447.1984.tb06859.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0447.1984.tb06859.x","pdf_url":null,"source":{"id":"https://openalex.org/S199498439","display_name":"Acta Psychiatrica Scandinavica","issn_l":"0001-690X","issn":["0001-690X","1600-0447"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Psychiatrica Scandinavica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2074636621"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065357743","display_name":"Gunnel Alfredsson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Alfredsson","raw_affiliation_strings":["Department of Psychiatry and Psychology, Karolinska Institute, S-10401 STOCKHOLM, Sweden (Head: Professor G Sedvall)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychology, Karolinska Institute, S-10401 STOCKHOLM, Sweden (Head: Professor G Sedvall)","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078554697","display_name":"Lars Bjerkenstedt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. Bjerkenstedt","raw_affiliation_strings":["Department of Psychiatry and Psychology, Karolinska Institute, S-10401 STOCKHOLM, Sweden (Head: Professor G Sedvall)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychology, Karolinska Institute, S-10401 STOCKHOLM, Sweden (Head: Professor G Sedvall)","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037831935","display_name":"Gunnar Edman","orcid":"https://orcid.org/0000-0003-0925-6304","observed_orcids":["https://orcid.org/0000-0003-0925-6304"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Edman","raw_affiliation_strings":["Department of Psychiatry and Psychology, Karolinska Institute, S-10401 STOCKHOLM, Sweden (Head: Professor G Sedvall)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychology, Karolinska Institute, S-10401 STOCKHOLM, Sweden (Head: Professor G Sedvall)","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078564859","display_name":"C. H\u00e4rnryd","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802208705","display_name":"Danderyds sjukhus","ror":"https://ror.org/00hm9kt34","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2802208705","https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. H\u00e4rnryd","raw_affiliation_strings":["Department of Psychiatry, Danderyd hospital, S-18288 DANDERYD, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Danderyd hospital, S-18288 DANDERYD, Sweden","institution_ids":["https://openalex.org/I2802208705"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109082935","display_name":"Gabriel Oxenstierna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Oxenstierna","raw_affiliation_strings":["Department of Psychiatry and Psychology, Karolinska Institute, S-10401 STOCKHOLM, Sweden (Head: Professor G Sedvall)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychology, Karolinska Institute, S-10401 STOCKHOLM, Sweden (Head: Professor G Sedvall)","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111511816","display_name":"G\u00f6ran Sedvall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Sedvall","raw_affiliation_strings":["Department of Psychiatry and Psychology, Karolinska Institute, S-10401 STOCKHOLM, Sweden (Head: Professor G Sedvall)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychology, Karolinska Institute, S-10401 STOCKHOLM, Sweden (Head: Professor G Sedvall)","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113624668","display_name":"F.\u2010A. Wiesel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F\u2010A WIESEL","raw_affiliation_strings":["Department of Psychiatry and Psychology, Karolinska Institute, S-10401 STOCKHOLM, Sweden (Head: Professor G Sedvall)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Psychology, Karolinska Institute, S-10401 STOCKHOLM, Sweden (Head: Professor G Sedvall)","institution_ids":["https://openalex.org/I28166907"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4880,"currency":"USD","value_usd":4880},"apc_paid":null,"fwci":2.7592,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":{"value":0.8953639,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"69","issue":"S311","first_page":"49","last_page":"74"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9649999737739563},{"id":"https://openalex.org/keywords/sulpiride","display_name":"sulpiride","score":0.9829999804496765},{"id":"https://openalex.org/keywords/chlorpromazine","display_name":"chlorpromazine","score":1.0},{"id":"https://openalex.org/keywords/cerebrospinal-fluid","display_name":"cerebrospinal fluid","score":0.8429999947547913},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.7570000290870667},{"id":"https://openalex.org/keywords/prolactin","display_name":"prolactin","score":0.7599999904632568},{"id":"https://openalex.org/keywords/monoamine-metabolites","display_name":"monoamine metabolites","score":0.6620000004768372},{"id":"https://openalex.org/keywords/homovanillic-acid","display_name":"homovanillic acid","score":0.8500000238418579},{"id":"https://openalex.org/keywords/5-hydroxyindoleacetic-acid","display_name":"5-hydroxyindoleacetic acid","score":0.9210000038146973},{"id":"https://openalex.org/keywords/mopeg","display_name":"MoPeG","score":0.7990000247955322},{"id":"https://openalex.org/keywords/dopaminergic-mechanisms","display_name":"dopaminergic mechanisms","score":0.7279999852180481},{"id":"https://openalex.org/keywords/phenothiazines","display_name":"phenothiazines","score":0.7070000171661377},{"id":"https://openalex.org/keywords/benzamide","display_name":"benzamide","score":0.7049999833106995}],"concepts":[{"id":"https://openalex.org/C2780806966","wikidata":"https://www.wikidata.org/wiki/Q422418","display_name":"Sulpiride","level":4,"score":0.9589149951934814},{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.7992967367172241},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.6536778211593628},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6086742281913757},{"id":"https://openalex.org/C42251903","wikidata":"https://www.wikidata.org/wiki/Q18391002","display_name":"Monoaminergic","level":4,"score":0.5831836462020874},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5299898982048035},{"id":"https://openalex.org/C2779651940","wikidata":"https://www.wikidata.org/wiki/Q54196","display_name":"Cerebrospinal fluid","level":2,"score":0.4906400740146637},{"id":"https://openalex.org/C3020081911","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Serum concentration","level":2,"score":0.4568030536174774},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.42847418785095215},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.4184114336967468},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39893412590026855},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2822829484939575},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.18925067782402039},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.14088353514671326},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07036921381950378},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.06201085448265076},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.0548936128616333}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002746","descriptor_name":"Chlorpromazine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002746","descriptor_name":"Chlorpromazine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002746","descriptor_name":"Chlorpromazine","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D002746","descriptor_name":"Chlorpromazine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006719","descriptor_name":"Homovanillic Acid","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006897","descriptor_name":"Hydroxyindoleacetic Acid","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008734","descriptor_name":"Methoxyhydroxyphenylglycol","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011388","descriptor_name":"Prolactin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D013469","descriptor_name":"Sulpiride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1600-0447.1984.tb06859.x","doi":"https://doi.org/10.1111/j.1600-0447.1984.tb06859.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0447.1984.tb06859.x","pdf_url":null,"source":{"id":"https://openalex.org/S199498439","display_name":"Acta Psychiatrica Scandinavica","issn_l":"0001-690X","issn":["0001-690X","1600-0447"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Psychiatrica Scandinavica","raw_type":"journal-article"},{"id":"pmid:6199949","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6199949","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta psychiatrica Scandinavica. Supplementum","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W343278875","https://openalex.org/W1518274760","https://openalex.org/W1553319166","https://openalex.org/W1999682710","https://openalex.org/W2011089108","https://openalex.org/W2019119509","https://openalex.org/W2033384960","https://openalex.org/W2048081131","https://openalex.org/W2048887295","https://openalex.org/W2049546683","https://openalex.org/W2050253244","https://openalex.org/W2050796527","https://openalex.org/W2065240317","https://openalex.org/W2075077125","https://openalex.org/W2080889861","https://openalex.org/W2085780181","https://openalex.org/W2089609495","https://openalex.org/W2165379748","https://openalex.org/W2167512497","https://openalex.org/W2298753418","https://openalex.org/W2300079107","https://openalex.org/W2412997161","https://openalex.org/W2413800352","https://openalex.org/W4294769719"],"related_works":["https://openalex.org/W2167512497","https://openalex.org/W2051363689","https://openalex.org/W2235716971","https://openalex.org/W2050796527","https://openalex.org/W1973934475","https://openalex.org/W189014912","https://openalex.org/W2064250035","https://openalex.org/W2004883510","https://openalex.org/W809020822","https://openalex.org/W2364618700"],"abstract_inverted_index":{"Schizophrenic":[0],"patients":[1,131,188,226,280,320,350],"were":[2,40,58,72,89,116,141],"treated":[3],"with":[4,189,227,293,323,333],"fixed":[5],"doses":[6,325],"of":[7,53,91,124,168,204,254,291],"sulpiride":[8,125,151,165,305,327],"(800":[9],"mg)":[10,14],"or":[11],"chlorpromazine":[12],"(400":[13],"during":[15],"eight":[16],"weeks":[17,49],"using":[18,64],"a":[19,282,307],"double-blind":[20],"design.":[21],"In":[22,163,200,239,317],"order":[23],"to":[24,35,177,181,214,218,249,252,269,288,330,335,352,356],"examine":[25],"relationships":[26],"between":[27,130,157],"pharmacokinetic,":[28],"clinical":[29,260,336],"and":[30,43,47,62,67,75,83,99,114,132,139,159,171,209,223,272,322,337],"biochemical":[31,338],"parameters":[32],"in":[33,60,101,112,126,137,144,147,174,185,198,221,237,246,278,281,348],"relation":[34],"treatment":[36,241],"the":[37,92,102,154,164,182,243,263,270,289,294,302,318,324,343],"following":[38],"variables":[39,71,88],"recorded":[41],"before":[42],"1,":[44],"2,":[45],"4":[46],"8":[48],"after":[50],"treatment.":[51],"Concentrations":[52],"sulpiride,":[54],"CPZ,":[55],"7-OH-CPZ,":[56],"nor1-CPZ":[57],"determined":[59],"serum":[61,113,127,138,158,222],"CSF":[63,115,140,160,175,247],"liquid":[65],"chromatography":[66],"mass":[68,108],"fragmentography.":[69,109],"Clinical":[70],"psychotic":[73,169,205,255],"morbidity":[74,170],"side":[76,84,191,229],"effects":[77,192,230,277],"as":[78,105],"evaluated":[79],"by":[80,107,118],"CPRS,":[81],"NOSIE":[82],"effect":[85,310],"ratings.":[86],"Monoaminergic":[87],"concentrations":[90,123,136,184,197,220,236,328,347],"major":[93],"cerebral":[94],"monoamine":[95],"metabolites,":[96],"HVA,":[97],"5-HIAA":[98],"MOPEG":[100,244],"cerebrospinal":[103],"fluid":[104],"measured":[106,117],"Prolactin":[110],"levels":[111],"radioimmunoassay.":[119],"During":[120],"steady":[121],"state,":[122],"varied":[128],"fourfold":[129],"CPZ":[133,235,341],"twentyfold.":[134],"Drug":[135],"highly":[142],"correlated":[143,217,251],"CPZ-but":[145],"not":[146],"sulpiride-treated":[148],"patients.":[149],"Although":[150],"passed":[152],"into":[153],"CSF,":[155],"transport":[156],"was":[161],"restricted.":[162],"group,":[166],"improvement":[167,203,253],"HVA":[172,207],"elevation":[173,208,211],"tended":[176,213,248,329],"be":[178,215,250,331,353],"negatively":[179],"related":[180],"drug":[183,196,219,346],"serum.":[186,199,238],"Sulpiride-treated":[187],"extrapyramidal":[190,228],"had":[193,232],"significantly":[194,233],"higher":[195,234],"CPZ-treated":[201,225],"patients,":[202],"morbidity,":[206],"prolactin":[210],"all":[212],"positively":[216],"CSF.":[224],"also":[231,300],"both":[240],"groups,":[242],"reduction":[245],"morbidity.":[256],"The":[257,298],"study":[258],"supplied":[259],"evidence":[261],"for":[262],"view":[264,303],"that":[265,304],"antipsychotic":[266,276],"drugs":[267],"belonging":[268],"phenothiazine":[271],"benzamide":[273],"series":[274],"induce":[275,357],"schizophrenic":[279,319],"graded":[283],"fashion":[284],"which":[285],"is":[286],"proportional":[287],"degree":[290],"interaction":[292],"central":[295,312],"dopaminergic":[296,313],"mechanisms.":[297],"results":[299],"support":[301],"has":[306],"more":[308],"selective":[309],"on":[311,342],"mechanisms":[314],"than":[315],"chlorpromazine.":[316],"studied":[321],"used,":[326],"maximal":[332],"regard":[334],"effects.":[339,359],"For":[340],"other":[344],"hand,":[345],"some":[349],"seemed":[351],"too":[354],"low":[355],"optimal":[358]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2074636621","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
